Abstract:The MtrCDE efflux pump of Neisseria gonorrhoeae exports a wide range of antimicrobial compounds that the gonococcus encounters at mucosal surfaces during colonization and infection and is a known gonococcal virulence factor. Here, we evaluate the role of this efflux pump system in strain FA1090 during in vivo human male urethral infection with N. gonorrhoeae using a controlled human infection model. With the strategy of competitive infections initiated with mixtures of wild-type FA1090 and an isogenic mutant FA1090 strain that does not contain a functional MtrCDE pump, we found that the presence of the efflux pump is not required for an infection to be established in the human male urethra. This finding contrasts with previous studies of in vivo infection in the lower genital tract of female mice, which demonstrated that mutant gonococci of a different strain (FA19) lacking a functional MtrCDE pump had a significantly reduced fitness compared to their wild-type parental FA19 strain. To determine if these conflicting results are due to strain or human vs . mouse differences, we conducted a series of systematic competitive infections in female mice with the same FA1090 strains as in humans, and with FA19 strains, including mutants that do not assemble a functional MtrCDE efflux pump. Our results indicate the fitness advantage provided by the MtrCDE efflux pump during infection of mice is strain dependent. Owing to the equal fitness of the two FA1090 strains in men, our experiments also demonstrated the presence of a colonization bottleneck of N. gonorrhoeae in the human male urethra, which may open a new area of inquiry into N. gonorrhoeae infection dynamics and control. TRIAL REGISTRATION . Clinicaltrials.gov NCT03840811. The work herein uses a unique controlled human infection model to examine the importance of a known Neisseria gonorrhoeae virulence factor, namely the multiple transferrable resistance (MtrCDE) efflux pump, to in vivo gonorrhea in human male urethra. The MtrCDE efflux pump is an important contributor to antimicrobial resistance because it enhances the ability of N. gonorrhoeae to withstand the action of multiple classes of antibiotics by facilitating the export of these compounds out of the bacterial cell. Antimicrobial resistant Neisseria gonorrhoeae is recognized by the US Centers for Disease Control as an urgent threat emerging in the antimicrobial resistance space and as a priority pathogen for antimicrobial resistance monitoring by the World Health Organization. Prior to the work described in this manuscript, studies performed in vitro and in vivo using the mouse model of infection had suggested that MtrCDE confers N. gonorrhoeae a within-host competitive advantage, even in the absence of antibiotic treatment, presumed to be related to the pump's ability to act on endogenous host derived antimicrobial factors. Our study demonstrates that the pump is not required for human infection and that it does not confer a competitive advantage in the human male urethral infection, at least in the context of the N. gonorrhoeae strain approved for use in experimental infections in humans. In addition, our study also revealed a previously unrecognized within-host bottleneck to the establishment of a productive urethral infection. Host bottlenecks have been described for other human pathogens, but never before for a bacterial sexually-transmitted pathogen. This observation opens an entirely new avenue of research inquiry that ultimately will help us better understand the pathogenesis of N. gonorrhoeae colonization and identify potential points for development of novel preventative measures.

Experimental genital tract infection demonstrates Neisseria gonorrhoeae MtrCDE efflux pump is not required for in vivo human infection and identifies gonococcal colonization bottleneck

Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae.

Moenomycin is broadly active against multidrug-resistant Neisseria gonorrhoeae and clears an infection from a murine vaginal tract infection model

Could Dampening Expression of the Neisseria Gonorrhoeae Mtrcde-Encoded Efflux Pump Be a Strategy to Preserve Currently or Resurrect Formerly Used Antibiotics to Treat Gonorrhea?

Impact of the Gonococcal FC428 Pena Allele 60.001 on Ceftriaxone Resistance and Biological Fitness.

High Percentage Of The Ceftriaxone-Resistant Neisseria Gonorrhoeae Fc428 Clone Among Isolates From A Single Hospital In Hangzhou, China

Both MisR (CpxR) and MisS (CpxA) Are Required for Neisseria gonorrhoeae Infection in a Murine Model of Lower Genital Tract Infection

Th1-polarized MtrE-based Gonococcal Vaccines Display Prophylactic and Therapeutic Efficacy.

Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae

Cryo-EM Structures of a Gonococcal Multidrug Efflux Pump Illuminate a Mechanism of Drug Recognition and Resistance

Transcriptome-guided metabolic network analysis reveals rearrangements of carbon flux distribution in Neisseria gonorrhoeae during neutrophil co-culture

A Subpopulation of Intracellular Neisseria Gonorrhoeae Escapes Autophagy-Mediated Killing Inside Epithelial Cells

Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125–1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea

[Prevention of Neisseria Gonorrhoeae Genital Tract Infection with Patented Technology of Physical Antimicrobial Dermal Film in a Murine Model].

Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections

Estimating the undetected burden of infections and the likelihood of strain persistence of drug-resistant Neisseria gonorrhoeae

Cyclization increases bactericidal activity of arginine-rich cationic cell-penetrating peptide for Neisseria gonorrhoeae

Folliculin Controls the Intracellular Survival and Trans-Epithelial Passage of Neisseria gonorrhoeae

Structure and Function of Neisseria Gonorrhoeae MtrF Illuminates a Class of Antimetabolite Efflux Pumps.

Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria

The Neisseria meningitidis urethritis clade ( Nm UC) acts as a "chimeric pathogen" during infection of primary, human male, urethral epithelial cells